Lower Reported Success Rates of Two-Stage Revisions for Periprosthetic Joint Infections Using Musculoskeletal Infection Society Outcome Reporting Tool at a Specialty Referral Center
The Journal of Arthroplasty · 2025
DOI: 10.1016/j.arth.2025.10.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Nicholas Tubin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada; Department of Surgery, University of Ottawa, Ottawa, ON, Canada. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Reoperation, Arthroplasty, Replacement, Hip, Hip Prosthesis. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The gold standard treatment for total hip arthroplasty (THA) periprosthetic joint infection (PJI) is a two-stage revision. Reported success rates are greater than 80%; however, significant differences remain in how treatment success rates are defined. The purpose of this study was to evaluate our specialized, tertiary hospital's experience with planned two-stage revisions for complex THA PJI. METHODS: Consecutive patients who underwent a planned two-stage revision for THA PJI at our institution over a 13-year period were assessed. Patients had a minimum 2-year follow-up, and those who had unplanned spacer retention were included. The primary outcome was treatment success defined by the Delphi Criteria and Musculoskeletal Infection Society Outcome Reporting Tool (Tiers 1 and 2). Failure for reimplantation (Tier 3F) was recorded. Baseline characteristics were collected. Factors associated with treatment outcome were analyzed. A total of 67 patients were identified at a mean follow-up of 8.6 years (range, 2.5 to 15.0). There were 16 patients who underwent previous surgeries for their PJI (23.9%). RESULTS: Utilizing the Musculoskeletal Infection Society Outcome Reporting Tool criteria, treatment success was achieved in 39 patients (58.2%) with reimplantation (Tier 1: 37 [55.2%], Tier 2: two [3%]). In contrast, an 86.6% success rate was noted when utilizing the Delphi criteria. Eighteen patients did not proceed with reimplantation and retained their spacers (Tier 3F). There were three patients (4.5%) who died during PJI treatment and 20 patients (29.9%) who were placed on chronic antibiotic suppression. Considering infection control with and without reimplantation, overall treatment success was achieved in 57 patients (85.1%). CONCLUSIONS: Our study suggests that two-stage revisions at specialized PJI referral centers may be less successful than previously reported and highlights discrepancies between reporting measures. As PJI care moves toward specialized PJI centers, where spacer retention may be more prevalent, there is a need for consistent and transparent reporting of outcomes when treating complex cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada; Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
- Division of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, ON, Canada.
Zitieren
APA
Tubin, N., Bonello, J. P., Abdelbary, H., Grammatopoulos, G., Beaulé, P. E., & Garceau, S. (2025). Lower Reported Success Rates of Two-Stage Revisions for Periprosthetic Joint Infections Using Musculoskeletal Infection Society Outcome Reporting Tool at a Specialty Referral Center. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2025.10.031
Vancouver
Tubin N, Bonello JP, Abdelbary H, Grammatopoulos G, Beaulé PE, Garceau S. Lower Reported Success Rates of Two-Stage Revisions for Periprosthetic Joint Infections Using Musculoskeletal Infection Society Outcome Reporting Tool at a Specialty Referral Center. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2025.10.031
BibTeX
@article{Tubin2025,
author = {Tubin, Nicholas and Bonello, John-Peter and Abdelbary, Hesham and Grammatopoulos, George and Beaulé, Paul-Edgar and Garceau, Simon},
title = {Lower Reported Success Rates of Two-Stage Revisions for Periprosthetic Joint Infections Using Musculoskeletal Infection Society Outcome Reporting Tool at a Specialty Referral Center},
journal = {The Journal of Arthroplasty},
year = {2025},
doi = {10.1016/j.arth.2025.10.031}
}
EUVIMED